Listener caller: AstraZeneca advice

Jim advises holding AstraZeneca and favors its portfolio over switching to ABI's yield.

Play episode from 09:23

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!